000 | 01046 a2200265 4500 | ||
---|---|---|---|
005 | 20250514031030.0 | ||
264 | 0 | _c20020925 | |
008 | 200209s 0 0 eng d | ||
022 | _a0176-3679 | ||
024 | 7 |
_a10.1055/s-2002-25029 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aEngfer, A | |
245 | 0 | 0 |
_aSoyka M, Bottlender R, Möller H-J; Epidemiological evidence for a low abuse potential of zolpidem; Pharmacopsychiatry 2000, 33: 138 - 141. _h[electronic resource] |
260 |
_bPharmacopsychiatry _cMar 2002 |
||
300 |
_a81; author reply 81-2 p. _bdigital |
||
500 | _aPublication Type: Letter; Comment | ||
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypnotics and Sedatives _xadverse effects |
650 | 0 | 4 |
_aPyridines _xadverse effects |
650 | 0 | 4 |
_aSubstance Withdrawal Syndrome _xpsychology |
650 | 0 | 4 |
_aSubstance-Related Disorders _xepidemiology |
650 | 0 | 4 | _aZolpidem |
773 | 0 |
_tPharmacopsychiatry _gvol. 35 _gno. 2 _gp. 81; author reply 81-2 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1055/s-2002-25029 _zAvailable from publisher's website |
999 |
_c11854053 _d11854053 |